[HTML][HTML] Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo
J Chen, B Yan, Q Chen, Y Yao, H Wang, Q Liu… - Archives of …, 2014 - Springer
Pandemic influenza A virus (H1N1) 2009 poses a serious public-health challenge
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo
J Chen, B Yan, Q Chen, Y Yao, H Wang, Q Liu… - Archives of …, 2014 - infona.pl
Pandemic influenza A virus (H1N1) 2009 poses a serious public-health challenge
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
J Chen, B Yan, Q Chen, Y Yao, H Wang… - Archives of …, 2014 - search.ebscohost.com
Pandemic influenza A virus (H1N1) 2009 poses a serious public-health challenge
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
[引用][C] Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo
J Chen, B Yan, Q Chen, Y Yao, H Wang, Q Liu… - Archives of …, 2014 - elibrary.ru
Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo
J Chen, B Yan, Q Chen, Y Yao, H Wang… - Archives of …, 2014 - pubmed.ncbi.nlm.nih.gov
Pandemic influenza A virus (H1N1) 2009 poses a serious public-health challenge
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
J Chen, B Yan, Q Chen, Y Yao, H Wang, Q Liu… - Archives of …, 2013 - europepmc.org
Pandemic influenza A virus (H1N1) 2009 poses a serious public-health challenge
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo
J Chen, B Yan, Q Chen, Y Yao, H Wang… - Archives of …, 2014 - search.proquest.com
Pandemic influenza A virus (H1N1) 2009 poses a serious public-health challenge
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo
J Chen, B Yan, Q Chen, Y Yao, H Wang, Q Liu… - Archives of …, 2014 - infona.pl
Pandemic influenza A virus (H1N1) 2009 poses a serious public-health challenge
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …